Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heat waves for pain? RF ablation study shows promise

NCT ID NCT04673032

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how well radiofrequency ablation (a procedure that uses heat to calm pain nerves) works for people with chronic pain. 298 participants were treated with a Boston Scientific device and then rated their improvement. The goal was to see real-world results, not to compare with other treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Radiofrequency ablation (a procedure using heat from radio waves to target nerves causing pain)
What this could lead to
If results are positive, this could support the use of radiofrequency ablation as a standard option for managing chronic pain.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. Pain relief varies, and the procedure may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

298 people

The number who actually took part.

Started

Dec 2020

Finished

Feb 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with Chronic Pain

Ages

0 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain per local Directions for Use (DFU) * Signed a valid, IRB/EC/REB-approved informed consent form Key Exclusion Criteria: * Meets any contraindications per locally applicable Directions for Use (DFU) * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain, chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carolinas Research Institute

    Huntersville, North Carolina, 28078, United States

  • Elite Pain and Spine Institute

    Mesa, Arizona, 85203, United States

  • Mater Olbia Hospital

    Olbia, Italy

  • Pain Diagnostics and Interventional Care

    Sewickley, Pennsylvania, 15143, United States

  • Premier Pain Treatment Institute

    Loveland, Ohio, 45140, United States

  • Quincy Medical Group

    Quincy, Illinois, 62301, United States

  • Shepherd Center

    Atlanta, Georgia, 30309, United States

  • St. Anna Hospital

    Geldrop, Netherlands

  • St. Jan

    Bruges, Belgium

  • The Spine Wellness Center in Westport

    Westport, Connecticut, 06880, United States

  • Toledo Clinic

    Toledo, Ohio, 43623, United States

  • Tucson Orthopaedic Institute

    Tucson, Arizona, 85712, United States

  • Twin Cities Pain Clinic and Surgery Center

    Edina, Minnesota, 55439, United States

  • UC Health Pain Medicine

    Cincinnati, Ohio, 45219, United States

  • ZNA Hoge Beuken

    Antwerp, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.